FDA Ortho Panel Will See Second Hip Resurfacing System In Cormet

Corin Group's Cormet will be the second hip resurfacing product to go before an FDA advisory committee when the Orthopaedic and Rehabilitation panel considers the device's PMA next month

More from Archive

More from Medtech Insight